Literature DB >> 25039623

Respiratory disease and respiratory physiology: putting lung function into perspective interstitial lung disease.

Norbert Berend1.   

Abstract

The interstitial lung diseases pathologically involve the pulmonary interstitium but may also involve the airways, pleura and pulmonary circulation. They may be idiopathic, be part of other conditions, or be related to drug or environmental exposures. This review will focus on diagnostic and prognostic information provided by lung function tests in the idiopathic interstitial pneumonias, particularly idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. These disorders are characterized by small stiff lungs with impaired gas exchange. Lung function tests, particularly lung volumes and gas transfer, used initially on patient presentation and then repeatedly on follow up, together with high-resolution computed tomography scans, can generate predictive formulae which are superior to single tests and can be used to provide useful information to assess the natural history of the disease or guide therapy. The concomitant presence of emphysema may mask the degree of restriction and may have adverse prognostic implications when accompanied by pulmonary hypertension.
© 2014 Asian Pacific Society of Respirology.

Entities:  

Keywords:  gas transfer; idiopathic pulmonary fibrosis; lung volume; non-specific interstitial pneumonia; restrictive lung disease

Mesh:

Year:  2014        PMID: 25039623     DOI: 10.1111/resp.12348

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  6 in total

1.  Pulmonary function test values due to a diaphragmatic hernia.

Authors:  Jesper Rømhild Davidsen; Leo Nygaard; Christian B Laursen; Daniel Pilsgaard Henriksen
Journal:  BMJ Case Rep       Date:  2016-08-12

2.  Extraction and Quantitation of Nicotinamide Adenine Dinucleotide Redox Cofactors.

Authors:  Wenyun Lu; Lin Wang; Li Chen; Sheng Hui; Joshua D Rabinowitz
Journal:  Antioxid Redox Signal       Date:  2017-07-19       Impact factor: 8.401

3.  Original Article: Clinical Research.

Authors:  Gulay Dasdemir Ilkhan; Fatma Demirci Üçsular; Hakan Celikhisar; Yücel Arman; Enver Yalnız; Tufan Tükek
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-06-28       Impact factor: 0.670

4.  Different KCO and VA combinations exist for the same DLCO value in patients with diffuse parenchymal lung diseases.

Authors:  Jean Pastre; Laurent Plantier; Carole Planes; Raphaël Borie; Hilario Nunes; Christophe Delclaux; Dominique Israël-Biet
Journal:  BMC Pulm Med       Date:  2015-09-03       Impact factor: 3.317

5.  Alpha-Mangostin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice Partly Through Activating Adenosine 5'-Monophosphate-Activated Protein Kinase.

Authors:  Ren-Shi Li; Gong-Hao Xu; Juan Cao; Bei Liu; Hai-Feng Xie; Yuji Ishii; Chao-Feng Zhang
Journal:  Front Pharmacol       Date:  2019-11-13       Impact factor: 5.810

6.  The economic burden of medical treatment of children with asthma in China.

Authors:  Ping Wu; Baoping Xu; Adong Shen; Zonglin He; Casper J P Zhang; Wai-Kit Ming; Kunling Shen
Journal:  BMC Pediatr       Date:  2020-08-18       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.